| Clinical Emergency Response System (CERS) - Management of the deteriorating patient
|
| Magnesium Chloride Intravenous Replacement for Electrolyte Replacement
|
| Magnesium Sulphate for Eclampsia or Eclampsia Prophylaxis
|
| Magnesium Sulphate Intravenous Administration for Electrolyte Disturbance
|
| Magnesium Sulphate Prior to Preterm Birth for Fetal Neuroprotection - MoHGL2022_006
|
| Management of Patients with Suspected or Identified Acute Stroke
|
| Mastitis (Lactational) Treatment - SESLHDPR/352
|
| Mastitis and Breast (Lactational) Abscess – Readmission for Treatment
|
| Maternal Collapse
|
| Medication - Access after hours
|
| Medication - Administration
|
| Medication - Medicines Reconciliation and Adverse Drug Reactions
|
| Medication - Prescribing
|
| Medication - Storage and Supply
|
| Mental Health Escalation - Maternity and Gynaecology - Inpatient
|
| Mental Health Escalation - Maternity and Gynaecology Outpatient
|
| Metaraminol
|
| Methotrexate - oral dosing and administration
|
| Methotrexate for ectopic pregnancy or unknown location (PUL)
|
| Midwifery Assessment and/or Admission
|
| Miscarriage - Medical Management
|
| Miscarriage – Surgical Management
|
| Monoamniotic Twins - Management
|
| Morphine - Subcutaneous (Maternity)
|
| Morphine Sulphate - Subcutaneous (non maternity)
|
| Nurse and Midwife Initiated Medicines Protocols
|
| Referral to Department of Maternal Fetal Medicine (MFM) - Fetal Indications
|
